BVF Partners L.P.
Investment Details
Investor Type
Private Investment Firm
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Series A, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, Singapore, France, Italy, Denmark, Switzerland, Spain, South Korea, Austria, Netherlands, New Zealand, Sweden, Belgium, Norway, Finland
Industries Focus
- Healthcare
- HealthTech
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Immunology
- Genomics
- Biopharmaceuticals
Investment Size:
5,000,000 to 100,000,000 USD
Investor Details Founded: 1993
BVF Partners L.P., established in 1993, is a private investment firm headquartered in San Francisco, California. The firm specializes in fundamentally-driven public biotechnology investments, focusing on small-cap biotechnology companies. BVF Partners employs a rigorous diligence process and ongoing monitoring to build concentrated, long-term investments in its portfolio companies. The firm's investment strategy includes private equity investments in early venture, middle market, buyouts, and industry consolidations. BVF Partners is committed to working with its portfolio companies as partners in their successes, providing both financial support and strategic guidance to foster growth and innovation in the biotechnology sector.
Requirements
- Companies must be in the biotechnology or life sciences sectors
- Preference for small-cap companies
- Focus on fundamentally-driven investments
- Interest in both public and private companies
- Willingness to engage in various investment strategies including private equity, buyouts, and industry consolidations
- Commitment to long-term partnerships with portfolio companies
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Autobahn Therapeutics
- Inmagene
- Mirum Pharmaceuticals
- Forward Therapeutics
- Septerna
- CG Oncology
- VistaGen Therapeutics
- Nimbus Therapeutics
- Syndax Pharmaceuticals
- Revolution Medicines
- Phathom Pharmaceuticals
- Vividion Therapeutics
- Prevail Therapeutics
- Peloton Therapeutics
- Relay Therapeutics
- Akero Therapeutics
- Verastem Oncology
- Essence Ventures
Mentioned In
-
$14.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of BVF Partners L.P.?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim